Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 1
2012 3
2013 3
2014 6
2015 2
2016 4
2017 5
2018 6
2019 7
2020 2
2021 6
2023 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Targeting aryl hydrocarbon receptor functionally restores tolerogenic dendritic cells derived from patients with multiple sclerosis.
Fondelli F, Willemyns J, Domenech-Garcia R, Mansilla MJ, Godoy-Tena G, Ferreté-Bonastre AG, Agúndez-Moreno A, Presas-Rodriguez S, Ramo-Tello C, Ballestar E, Martínez-Cáceres E. Fondelli F, et al. Among authors: mansilla mj. J Clin Invest. 2024 Nov 1;134(21):e178949. doi: 10.1172/JCI178949. J Clin Invest. 2024. PMID: 39287981 Free PMC article.
Ethyl Pyruvate Induces Tolerogenic Dendritic Cells.
Djedovic N, Mansilla MJ, Jevtić B, Navarro-Barriuso J, Saksida T, Martínez-Cáceres EM, Miljković Ð. Djedovic N, et al. Among authors: mansilla mj. Front Immunol. 2019 Feb 7;10:157. doi: 10.3389/fimmu.2019.00157. eCollection 2019. Front Immunol. 2019. PMID: 30792716 Free PMC article.
Heat shock protein 70: roles in multiple sclerosis.
Mansilla MJ, Montalban X, Espejo C. Mansilla MJ, et al. Mol Med. 2012 Sep 7;18(1):1018-28. doi: 10.2119/molmed.2012.00119. Mol Med. 2012. PMID: 22669475 Free PMC article. Review.
Paving the way towards an effective treatment for multiple sclerosis: advances in cell therapy.
Mansilla MJ, Presas-Rodríguez S, Teniente-Serra A, González-Larreategui I, Quirant-Sánchez B, Fondelli F, Djedovic N, Iwaszkiewicz-Grześ D, Chwojnicki K, Miljković Đ, Trzonkowski P, Ramo-Tello C, Martínez-Cáceres EM. Mansilla MJ, et al. Cell Mol Immunol. 2021 Jun;18(6):1353-1374. doi: 10.1038/s41423-020-00618-z. Epub 2021 May 6. Cell Mol Immunol. 2021. PMID: 33958746 Free PMC article. Review.
Cell-based Tolerogenic Therapy, Experience from Animal Models of Multiple Sclerosis, Type 1 Diabetes and Rheumatoid Arthritis.
Stojanovic I, Dimitrijevic M, Vives-Pi M, Mansilla MJ, Pujol-Autonell I, Rodríguez-Fernandez S, Palova-Jelínkova L, Funda DP, Gruden-Movsesijan A, Sofronic-Milosavljevic L, Hilkens CMU, Martinez-Caceres E, Miljkovic D. Stojanovic I, et al. Among authors: mansilla mj. Curr Pharm Des. 2017;23(18):2623-2643. doi: 10.2174/1381612823666170214120708. Curr Pharm Des. 2017. PMID: 28201972 Review.
Assessing Blood-Based Biomarkers to Define a Therapeutic Window for Natalizumab.
Granell-Geli J, Izquierdo-Gracia C, Sellés-Rius A, Teniente-Serra A, Presas-Rodríguez S, Mansilla MJ, Brieva L, Sotoca J, Mañé-Martínez MA, Moral E, Bragado I, Goelz S, Martínez-Cáceres E, Ramo-Tello C. Granell-Geli J, et al. Among authors: mansilla mj. J Pers Med. 2021 Dec 10;11(12):1347. doi: 10.3390/jpm11121347. J Pers Med. 2021. PMID: 34945819 Free PMC article.
Liposome-based immunotherapy against autoimmune diseases: therapeutic effect on multiple sclerosis.
Pujol-Autonell I, Mansilla MJ, Rodriguez-Fernandez S, Cano-Sarabia M, Navarro-Barriuso J, Ampudia RM, Rius A, Garcia-Jimeno S, Perna-Barrull D, Martinez-Caceres E, Maspoch D, Vives-Pi M. Pujol-Autonell I, et al. Among authors: mansilla mj. Nanomedicine (Lond). 2017 Jun;12(11):1231-1242. doi: 10.2217/nnm-2016-0410. Nanomedicine (Lond). 2017. PMID: 28593827
42 results